In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Gelesis Inc.

www.gelesis.com

Latest From Gelesis Inc.

Global Device Approvals Snapshot: April 9-15, 2019

A snapshot of global medical device approvals captured during the past week in Medtech Insight's Approvals Tracker. This week, FDA approved Qiagen's therascreen FGFR RGQ RT-PCR companion diagnostic for Janssen's new drug to treat specific types of urothelial cancer and Intact Vascular's Tack device to treat dissections of the above-the-knee peripheral arteries following angioplasty.

Research & Development Approvals

Gelesis's Obesity Product FDA Acceptance Gives Boost To PureTech's Portfolio


PureTech's affiliate Gelesis has received FDA clearance for its Plenity capsule to treat overweight-obese adults, and plans to launch it commercially in the second half. 
Approvals Metabolic Disorders

Appointments: Gilead, Shield Therapeutics, Gelesis, TG Therapeutics, Aziyo Biologics, Allogene Therapeutics, Mesoblast and CGT Catapult Make New Hires

Latest appointments announced by pharma and biotech firms.

 

Appointments BioPharmaceutical

Gelesis Absorbs Clinical Affairs and Commercial Expertise With New Appointments

Gelesis reels in former Walgreens and Boehringer Ingelheim execs as it prepares to take its anti-obesity capsule-based treatment towards regulatory approvals.

Metabolic Disorders Appointments
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
  • Pharmaceuticals
  • Therapeutic Areas
  • Gastrointestinal
  • Hepatic (Liver)
  • Metabolic Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Gelesis Inc.
  • Senior Management
  • Yishai Zohar, CEO
    Harry Leider, CMO
  • Contact Info
  • Gelesis Inc.
    Phone: (617) 482-2333
    500 Boylston St., Ste. 1600
    Boston, MA 02116
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register